Alnylam Pharmaceuticals, Inc. (ALNY) — Hedge Fund Ownership Q4 2025
ALNY
- Alnylam Pharmaceuticals, Inc. (ALNY) is held by 1 of 82 tracked hedge funds, with Dodge & Cox (0.4%) holding the largest stake, indicating limited hedge fund interest relative to peers.
- The biggest decreases in ALNY holdings came from Dodge & Cox (-15%), suggesting profit-taking or de-risking.
- 1 hedge fund exited ALNY.
- Overall, hedge funds decreased exposure to Alnylam Pharmaceuticals, Inc. (ALNY) by -15% vs the prior quarter and -45% vs prior year.
| # | Fund | % of Portfolio † | Shares † | Shares vs Prior Quarter † | Shares vs Prior Year † | Aggregate Value † | Reported Price * | Option |
|---|---|---|---|---|---|---|---|---|
| 1 |
Dodge & Cox
|
0.42% | 2.0M | -15.37% | -44.51% | $781.1M | $397.65 | — |
| — |
Polen Capital Management
|
— | — | EXITED | — | — | — | — |
| 1 | Total | — | 2.0M | -15.40% | -44.51% | $781.1M | — | — |
* Reported price is not an actual purchase or sale price. It is the price as of the last portfolio date.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.
† Portfolio value, share counts, and period-over-period changes exclude options positions (PUT/CALL), which are shown in the Option column for reference only.